Pharma Journal

Pharma player Granules India has inked a memorandum of understanding (MoU) with ..

Read more at:

Granules India & NIPER Mohali partner for CoE - ET HealthWorld | Pharma Medicine: This CoE will focus on crucial areas such as exploring plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods in producing directly compressible crystals, promotion of solvent-free pharmaceutical processes, and the development of resource-effic...

Nector Lifesciences unit at Himachal Pradesh Plant has received untitled letter from FDA for repeated GMP violations.

The untitled letter, published by the FDA on Wednesday, reveals that some observations had been previously noted during an inspection back in January 2014, with inspectors noting that “repeated failures demonstrate that executive management oversight and control over the manufacture of drugs is inadequate.”

Nectar Lifesciences hit with untitled letter over repeat GMP issues at antimicrobial site Indian API manufacturer Nectar Lifesciences late last month received an untitled letter from the FDA over repeat GMP violations, the FDA said, following a seven-day inspection at its Unit VI site in Himachal Pradesh, India, last March. During the inspections, the FDA uncovered improper aseptic manuf...